Article

Jenna Forsythe Gives Advice to Patients Newly Diagnosed with Cancer

Jenna Forsythe, an oncology nurse at John Theurer Cancer Center in Hackensack, New Jersey, says many patients newly diagnosed with cancer will need to allow themselves to lean on their medical team, especially in regards to symptom management.

Jenna Forsythe, an oncology nurse at John Theurer Cancer Center in Hackensack, New Jersey, says many patients newly diagnosed with cancer will need to allow themselves time to adjust and to lean on their medical team.

"Once they get both feet on the ground and realize it's going to change, (they can) realize that there will be ways to manage this,” she says. “They have the whole multidisciplinary team to refer to.”

She encourages patients to be upfront with their medical team on side effects or other issues related to care. If they are hesitant to talk to their doctor about their side effects, she suggests talking with one of the nursing staff. “We’re their middle man. We’re there to help them.”

Forsythe says some patients worry their oncologist could take them off treatment or say there is nothing more they can do for them if the side effects are too severe, “but there are so many options out there for them now.”

Being proactive about symptom management is very important over the long-term. “If we can get rid of the side effects and manage their symptoms early on, they are going to have better outcomes,” she says.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Image of woman.
Image of two doctors and text.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Image of two doctors and text.
Related Content